Tirzepatide's innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health.
Tirzepatide 在 2 型糖尿病管理中的創新應用及其在心血管健康中的未來前景。
Front Pharmacol 2024-09-12
The effects of acute aerobic exercise on appetite-regulating parameters and energy intake in males with obesity.
急性有氧運動對肥胖男性食慾調節參數和能量攝入的影響。
Health Sci Rep 2024-09-12
Efficacy and safety of semaglutide combined with metformin in treating T2DM with overweight or obesity: a systematic review and meta-analysis.
semaglutide 與 metformin 結合治療超重或肥胖的 2 型糖尿病的療效與安全性：系統性回顧與統合分析。
Am J Transl Res 2024-09-12
Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review.
多囊卵巢症候群女性使用胰高血糖素樣肽-1激動劑減重的臨床效果：範疇回顧。
Cureus 2024-09-12
[A new era for incretins : from GLP-1 receptor agonists to co-agonists and poly-agonists].
「胰高血糖素樣肽-1 受體激動劑到共激動劑和多重激動劑：胰島素增效劑的新時代」
Rev Med Liege 2024-09-12
Biomolecules of Adipose Tissue in Atherosclerotic Plaques of Men With Coronary Atherosclerosis.
冠狀動脈動脈粥樣硬化男性的動脈粥樣硬化斑塊中的脂肪組織生物分子。
Kardiologiia 2024-09-12
Polysaccharide NAP-3 Synergistically Enhances the Efficiency of Metformin in Type 2 Diabetes via Bile Acid/GLP-1 Axis through Gut Microbiota Remodeling.
多醣體 NAP-3 透過腸道微生物重塑，協同增強 Metformin 在 2 型糖尿病中的療效，作用於膽酸/GLP-1 軸。
J Agric Food Chem 2024-09-12